FDA Inspection 1293328 - Guangdong Lewwin Pharmaceutical Research Institute - November 14, 2025

FDA Inspection 1293328 for Guangdong Lewwin Pharmaceutical Research Institute on November 14, 2025. Classification: N/A.

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA Inspection 1293328 for Guangdong Lewwin Pharmaceutical Research Institute on November 14, 2025. Classification: N/A.

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Guangdong Lewwin Pharmaceutical Research Institute

Inspection Date

November 14, 2025

Product Type

Human Drugs

Office

Office of Inspections and Investigations

ID: ffd903bc-6de1-4abd-8e7a-3003d30b3305

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox